Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Bima Sakti Pertiwi Tbk. (PAMG) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Bima Sakti Pertiwi Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Bima Sakti Pertiwi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 319B, 50.8K 24h volume), while Bima Sakti Pertiwi Tbk. trades at Rp56 (market cap 175B, 5.09M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Bima Sakti Pertiwi Tbk. is more actively traded (5.09M versus 50.8K). Which is the better fit depends on your goals.

DGNSPAMG
Market Cap
319B175B
Volume
50.8K5.09M
Lot
50850.94K
Turnover
11.61M286.11M
Average Price
228.4756.16
Value
11.61M286.11M
Indicative Equilibrium Price
23257
Indicative Equilibrium Volume
200606

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PAMG
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Bima Sakti Pertiwi Tbk.

PT Bima Sakti Pertiwi Tbk (the Company) was established based on the Notarial Deed of Raden Minarno Hardjokoesoemo, S.H., Deputy Notary in Tanjungpinang, No. 30, dated April 28, 1980.

Read more on PAMG